|
2021-03-05
|
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines
published
| article-journal
doi:10.1016/j.chom.2021.03.002
|
|
2021-12-15
|
Towards A Population-Based Threshold of Protection for COVID-19 Vaccines
published
| article-journal
| CC-BY-NC-ND
doi:10.1016/j.vaccine.2021.12.006
|
|
2022-02-24
|
Boosting immunity to Omicron
published
| article-journal
doi:10.1038/s41591-022-01727-0
|
|
2021-11-02
|
A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice
published
| article-journal
doi:10.1126/scitranslmed.abj7125
|
|
2021-07-15
|
A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates
published
| article-journal
| CC-BY
doi:10.1126/sciimmunol.abh3634
|
|
2021-06-04
|
Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates
published
| article-journal
doi:10.1371/journal.ppat.1009624
|
|
2022-07-22
|
A clade C HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques
published
| article-journal
doi:10.1126/sciimmunol.abl4102
|
|
2022-09-13
|
Data presented in Multi-trial analysis of HIV-1 envelope gp41-reactive antibodies among global recipients of candidate HIV-1 vaccines.
published
| dataset
| 1.0.0
| CC-BY
doi:10.5281/zenodo.7063076
|
|
2022-09-13
|
Data presented in Multi-trial analysis of HIV-1 envelope gp41-reactive antibodies among global recipients of candidate HIV-1 vaccines.
published
| dataset
| 1.0.0
| CC-BY
doi:10.5281/zenodo.7063075
|
|
2022-09-22
|
Data presented in Multi-trial analysis of HIV-1 envelope gp41-reactive antibodies among global recipients of candidate HIV-1 vaccines
published
| dataset
| CC-BY
doi:10.6084/m9.figshare.21178468
|
|
2022-12-01
|
Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge one year later
published
| article-journal
doi:10.1126/scitranslmed.add6383
|
|
2023-03-07
|
Direct intranodal tonsil vaccination with modified vaccinia Ankara vaccine protects macaques from highly pathogenic SIVmac251
published
| article-journal
doi:10.1038/s41467-023-36907-0
|
|
2023-08-14
|
Mutational basis of serum cross-neutralization profiles elicited by infection or vaccination with SARS-CoV-2 variants
published
| unknown type
doi:10.1101/2023.08.13.553144
|
|
2023-08-31
|
Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results
published
| article-journal
doi:10.1038/s41591-023-02517-y
|
|
2023-11-04
|
A combined adjuvant approach primes robust germinal center responses and humoral immunity in non-human primates
published
| article-journal
doi:10.1038/s41467-023-42923-x
|
|
2023-10-24
|
Host immunity associated with spontaneous suppression of viremia in therapy-naïve young rhesus macaques following neonatal SHIV infection
published
| article-journal
doi:10.1128/jvi.01094-23
|
|
2023-12-12
|
Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccines
published
| article-journal
doi:10.1128/jvi.01478-23
|
|
2024-02-05
|
Mapping SARS-CoV-2 antigenic relationships and serological responses
published
| dataset
| 3
| CC-0
doi:10.5061/dryad.b8gtht7jf
|
|
2020-03-12
|
Engagement of monocytes, NK cells, and CD4+ Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIVmac251 vaginal acquisition
published
| article-journal
doi:10.1371/journal.ppat.1008377
|
|
2024-05-15
|
Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays
published
| article-journal
doi:10.1126/scitranslmed.adl1722
|
|
2013-09-26
|
Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial
published
| article-journal
| v1
doi:10.60692/31xs5-tqt93
|
|
2018-04-01
|
HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis
published
| article-journal
| v1
doi:10.60692/797y4-qj298
|
|
2018-04-15
|
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees
published
| article-journal
| v1
doi:10.60692/bhyfz-6gg37
|
|
2013-09-26
|
Plasma IgG to Linear Epitopes in the V2 and V3 Regions of HIV-1 gp120 Correlate with a Reduced Risk of Infection in the RV144 Vaccine Efficacy Trial
published
| article-journal
| v1
doi:10.60692/qtmfc-vtq87
|
|
2013-01-17
|
Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
published
| article-journal
| v1
doi:10.60692/h0wp5-wav71
|
|
2018-04-15
|
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees
published
| article-journal
| v1
doi:10.60692/yt17w-n3f51
|
|
2013-05-09
|
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
published
| article-journal
| v1
doi:10.60692/h2gz0-1qp85
|
|
2014-10-02
|
Aggregate complexes of HIV-1 induced by multimeric antibodies
published
| article-journal
| v1
doi:10.60692/ecq19-fr191
|
|
2018-04-01
|
HIV-1-Specific IgA Monoclonal Antibodies from an HIV-1 Vaccinee Mediate Galactosylceramide Blocking and Phagocytosis
published
| article-journal
| v1
doi:10.60692/q1vrg-sx144
|
|
2024-10-22
|
Short CDRL1 in intermediate VRC01-like mAbs is not sufficient to overcome key glycan barriers on HIV-1 Env
published
| article-journal
| CC-BY
doi:10.1128/jvi.00744-24
|
|
2024-11-27
|
Neonatal immunity associated with heterologous HIV-1 neutralizing antibody induction in SHIV-infected Rhesus Macaques
published
| article-journal
doi:10.1038/s41467-024-54753-6
|
|
2024-08-30
|
Immunization with germ line-targeting SOSIP trimers elicits broadly neutralizing antibody precursors in infant macaques
published
| article-journal
doi:10.1126/sciimmunol.adm7097
|
|
2025-04-23
|
Distinct immune responses in people living with HIV following SARS-CoV-2 recovery
published
| article-journal
doi:10.1038/s43856-025-00839-1
|
|
2023-10-06
|
Mapping SARS-CoV-2 antigenic relationships and serological responses
published
| article-journal
doi:10.1126/science.adj0070
|
|
2022-09-22
|
Data presented in Multi-trial analysis of HIV-1 envelope gp41-reactive antibodies among global recipients of candidate HIV-1 vaccines
published
| dataset
| v1
| CC-BY
doi:10.6084/m9.figshare.21178468.v1
|
|
2013-01-17
|
Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
published
| article-journal
| v1
doi:10.60692/vs5ej-cmp87
|
|
2014-10-02
|
Aggregate complexes of HIV-1 induced by multimeric antibodies
published
| article-journal
| v1
doi:10.60692/fsp4w-08183
|
|
2014-01-01
|
Aggregate complexes of HIV-1 induced by multimeric antibodies
published
| article-journal
| v1
doi:10.60692/h2cvx-96937
|
|
2014-01-01
|
Aggregate complexes of HIV-1 induced by multimeric antibodies
published
| article-journal
| v1
doi:10.60692/3wj2k-zn894
|
|
2025-01-28
|
A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses
published
| article-journal
doi:10.3390/vaccines13020133
|
|
2025-05-15
|
Convergence and divergence of B cell responses in two HIV-1 Env immunizations in Rhesus macaques
published
| article-journal
doi:10.1038/s43856-025-00899-3
|
|
2013-05-09
|
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG
published
| article-journal
| v1
doi:10.60692/gcq8q-qnx83
|
|
2024-11-29
|
Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques
published
| post
| CC-BY
doi:10.1101/2024.11.27.625755
|
|
2024-12-18
|
Computationally Selected Multivalent HIV-1 Subtype C Vaccine Protects Against Heterologous SHIV Challenge
unknown status
| post
| CC-BY
doi:10.20944/preprints202412.1501.v1
|
|
2025-02-24
|
Computationally Selected Multivalent HIV-1 Subtype C Vaccine Protects Against Heterologous SHIV Challenge
published
| article-journal
doi:10.3390/vaccines13030231
|